Yale Cancer Center

Covid-19 Blood Clotting Cause Identified in Study

29-Jun-2020 1:15 PM EDT, by Yale Cancer Center contact patient services

Newswise — One of the major mysteries in treating patients with Covid-19 is the frequent development of blood clots that can subsequently damage their organs and sometimes be fatal. New findings led by Yale Cancer Center (YCC) researchers and experts across several medical specialties at Yale identify a leading mechanism behind the pathophysiology of Covid-19 and pinpoint a biological marker for the mechanism that may aid in treating these patients. The study was published today in The Lancet Haematology.

“While many forms of illness can generate blood clots, the endothelial cells that line the inside of blood vessels play a surprisingly large role in Covid-19 clotting,” said Alfred Lee, M.D., Ph.D., Associate Professor of Medicine (Hematology) at YCC and co-senior author on the paper. “Endothelial damage is a central component in the entire spectrum of Covid-19 disease. Our study is the first to demonstrate that this process of endothelial damage is present in a wide range of Covid-19 patients, particularly as people become critically ill.”

The clinical study examined the blood of 68 patients with Covid-19, 48 of them critically ill in an intensive care unit (ICU) and 20 receiving care on a non-ICU hospital unit, along with 13 disease-free volunteers who acted as a control arm. Several markers of endothelial cell and blood platelet activation were about twice as high in the ICU group than in the non-ICU group, and also higher in the non-ICU group than in the control group.

One of the biomarkers, a soluble form of a protein on the surface of endothelial cells called thrombomodulin, was highly correlated with survival among all Covid-19 patients. This finding suggests that measuring thrombomodulin levels might aid in managing patients. “If we have a marker to identify which patients are most likely to progress towards critical illness and possibly death, that would be hugely helpful, as these patients might benefit from closer monitoring and possibly earlier intervention,” said Lee.

Hyung Chun, M.D., FAHA, Associate Professor of Medicine (Cardiology) and Pathology at Yale School of Medicine, Director of Translational Research in the Yale Pulmonary Vascular Disease Program and co-senior author on the paper, is now exploring opportunities to develop a diagnostic test based on thrombomodulin, which is also elevated in other life-threatening diseases.

“The other goal we’re pursuing in parallel is to find therapeutic strategies that could safeguard the endothelial layer and may prevent the blood clots from forming,” said Chun, whose lab studies endothelial cells. “Are there approved drugs we could potentially repurpose for this context, or could we think about other mechanisms to come up with novel therapies to ultimately protect endothelial cells?”

One early candidate among approved therapies is an oral drug called dipyridamole, long used to prevent stroke and for other conditions. The research began with a Yale Covid-19 initiative that brought together medical experts charged with making recommendations on standard treatments for the Yale New Haven Health System.

Clinical fellows George Goshua, M.D., and Alexander Pine, M.D., Ph.D., both in the hematology/oncology fellowship training program at Yale Cancer Center, and M.D./Ph.D. student Matthew Meizlish are co-first authors on the paper. Altogether, 23 Yale physicians and researchers contributed to the work. “As terrible as it is, Covid-19 brought people together who almost never would have the chance to intersect, so that we could all exchange amazing ideas and learn from each other and accomplish great science,” Lee added.

The study was supported by a gift from Jack Levin to Yale’s Benign Hematology program and by the National Institutes of Health.

About Yale Cancer Center and Smilow Cancer Hospital

Yale Cancer Center (YCC) is one of only 51 National Cancer Institute (NCI)-designated comprehensive cancer centers in the nation and the only such center in Connecticut. Cancer treatment for patients is available at Smilow Cancer Hospital through 13 multidisciplinary teams and at 15 Smilow Cancer Hospital Care Centers in Connecticut and Rhode Island. Smilow Cancer Hospital is accredited by the Commission on Cancer, a Quality program of the American College of Surgeons. Comprehensive cancer centers play a vital role in the advancement of the NCI’s goal of reducing morbidity and mortality from cancer through scientific research, cancer prevention, and innovative cancer treatment.

 

                                                                                                   #  #  #

 




Filters close

Showing results

110 of 2776
Newswise:Video Embedded protocol-needed-to-monitor-covid-19-disease-course
VIDEO
Released: 3-Aug-2020 9:05 PM EDT
Protocol needed to monitor COVID-19 disease course
University of Washington School of Medicine and UW Medicine

Patients with underlying conditions such as asthma or other lung problems should be checked on regularly by pulmonologists or primary-care doctors for at least six months. Some will need to be monitored for one to three years, according to a new opinion piece posted online today in The Lancet-Respiratory Medicine.

Newswise: UM Cardiology Researchers Studying How COVID-19 Affects the Heart
Released: 3-Aug-2020 3:10 PM EDT
UM Cardiology Researchers Studying How COVID-19 Affects the Heart
University of Miami Health System, Miller School of Medicine

COVID-19 is shown to impact the heart and, in some cases, have long-lasting cardiac effects. To discover the extent to which COVID-19 affects the heart, cardiologists and researchers with the University of Miami Miller School of Medicine have begun multiple studies.

Newswise: Tackling the Bioethics Challenges Raised by COVID-19
Released: 3-Aug-2020 3:05 PM EDT
Tackling the Bioethics Challenges Raised by COVID-19
University of Pennsylvania School of Nursing

The diverse situations experienced by health-care workers during the COVID-19 pandemic often present serious ethical challenges. From the allocation of resources and triage protocols to health-care worker and patient rights and the management of clinical trials, new ethical questions have come to the forefront of today’s global public health emergency.

Newswise: 239156_web.jpg
Released: 3-Aug-2020 2:50 PM EDT
New species of fungus sticking out of beetles named after the COVID-19 quarantine
Pensoft Publishers

A major comprehensive study on Herpomycetales and Laboulbeniales, two orders of unique ectoparasitic fungi associated with insects and other arthropods (class Laboulbeniomycetes) in Belgium and the Netherlands was published in the open-access, peer-reviewed scholarly journal MycoKeys.

Released: 3-Aug-2020 1:30 PM EDT
Consumer Behavior Has Shifted Significantly During Pandemic, Survey Reveals
Rensselaer Polytechnic Institute (RPI)

The COVID-19 pandemic has brought about an increase in telework and online commerce, and a significant decrease in the number of personal trips people are making. Understanding the effects of these rapid changes on the economy, supply chains, and the environment will be essential, as some of these behaviors will continue even after the pandemic has ended. Researchers from Rensselaer Polytechnic Institute recently presented the results of two sets of surveys they conducted in an effort to quantify and understand these unprecedented shifts.

access_time Embargo lifts in 2 days
Embargo will expire: 5-Aug-2020 12:05 AM EDT Released to reporters: 3-Aug-2020 12:25 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 5-Aug-2020 12:05 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

31-Jul-2020 4:05 PM EDT
The effects of COVID-19 on emergency visits, hospitalizations
Mayo Clinic

COVID-19 swept into the U.S., hospitals across the country have reported that their emergency departments are emptying out. In a new study published Monday, Aug. 3, in JAMA Internal Medicine, a team of researchers from multiple institutions provides insights into this phenomenon.

Newswise: Important Dementia Studies Continuing at UK Despite Ongoing COVID-19 Pandemic
Released: 3-Aug-2020 10:20 AM EDT
Important Dementia Studies Continuing at UK Despite Ongoing COVID-19 Pandemic
University of Kentucky

The COVID-19 pandemic brought many things to a screeching halt and continues to impact our daily lives. However, important research at the University of Kentucky’s Sanders-Brown Center on Aging (SBCoA) is continuing under extreme caution and deep dedication. A monumental study in the field of dementia research is set to get underway in the coming weeks at UK.


Showing results

110 of 2776

close
1.61302